Published in Nat Med on May 01, 1998
Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A (2005) 2.70
Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J Virol (2000) 1.81
Antiviral effects of an iminosugar derivative on flavivirus infections. J Virol (2002) 1.80
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J Gastroenterol (2007) 1.77
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci U S A (1999) 1.54
A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion. Antimicrob Agents Chemother (2007) 1.27
Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. J Virol (2001) 1.26
Hepatitis B virus resistance to antiviral drugs: where are we going? Liver Int (2011) 1.21
Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology (2014) 1.19
Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection. EMBO J (1998) 1.09
Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo. Antiviral Res (2010) 1.09
Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses. Antimicrob Agents Chemother (2009) 1.04
Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release. Antimicrob Agents Chemother (2010) 1.03
The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery? Br J Pharmacol (2011) 1.02
Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication. J Med Chem (2011) 1.01
Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection. Antiviral Res (2011) 0.99
Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders. Philos Trans R Soc Lond B Biol Sci (2003) 0.99
The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep (2015) 0.98
Experimental models and therapeutic approaches for HBV. Semin Immunopathol (2012) 0.95
Antiviral treatment of chronic hepatitis B virus (HBV) infections. Viruses (2010) 0.93
Antiviral therapies and prospects for a cure of chronic hepatitis B. Cold Spring Harb Perspect Med (2015) 0.93
Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins. Biochem J (2002) 0.92
Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme. J Virol (2005) 0.90
Therapeutic strategies for a functional cure of chronic hepatitis B virus infection. Acta Pharm Sin B (2014) 0.89
Structure and glycosylation patterns of surface proteins from woodchuck hepatitis virus. J Virol (1998) 0.89
The alkylated imino sugar, n-(n-Nonyl)-deoxygalactonojirimycin, reduces the amount of hepatitis B virus nucleocapsid in tissue culture. J Virol (2003) 0.89
Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation. Biochem J (2003) 0.89
Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus. Antimicrob Agents Chemother (2004) 0.88
Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection. J Med Chem (2012) 0.85
Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks. Hepatology (2010) 0.84
Current and future antiviral drug therapies of hepatitis B chronic infection. World J Hepatol (2015) 0.83
Structure-activity relationship of a new class of anti-hepatitis B virus agents. Antimicrob Agents Chemother (2002) 0.81
Novel approaches towards conquering hepatitis B virus infection. World J Gastroenterol (2007) 0.80
Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents. Emerg Microbes Infect (2013) 0.79
Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck. Med Microbiol Immunol (2014) 0.76
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance. PLoS One (2015) 0.75
Emerging drugs for hepatitis B. Expert Opin Emerg Drugs (2007) 0.75
Intrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylation. Sci Rep (2016) 0.75
Combination therapy for hepatitis B. Gut (2002) 0.75
Iminosugars: Promising therapeutics for influenza infection. Crit Rev Microbiol (2016) 0.75
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 11.94
Protein interaction mapping in C. elegans using proteins involved in vulval development. Science (2000) 11.61
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med (1967) 7.00
Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis. Nature (1968) 6.34
Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet (2001) 5.67
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science (2001) 5.39
Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature (1985) 5.32
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis (1999) 4.67
Glycobiology. Annu Rev Biochem (1988) 4.51
Glycosylation and the immune system. Science (2001) 4.39
ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell (2001) 4.38
Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med (1968) 4.28
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad Sci U S A (1998) 3.88
Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J Virol (2000) 3.74
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis (2000) 3.63
An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med (1969) 3.54
Glycosyl-phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane. Science (1988) 3.41
Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med (1995) 3.38
Parallel neural networks for learning sequential procedures. Trends Neurosci (1999) 3.35
The Caenorhabditis elegans locus lin-15, a negative regulator of a tyrosine kinase signaling pathway, encodes two different proteins. Genetics (1994) 3.09
Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature (2001) 3.07
Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol (1993) 2.92
Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature (1995) 2.79
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature (2001) 2.78
Gm Phenotypes and Genotypes in U. S. Whites and Negroes; in American Indians and Eskimos; in Africans; and in Micronesians. Am J Hum Genet (1961) 2.72
Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem (1998) 2.67
Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol (1998) 2.66
Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature (1992) 2.52
Regulation of Hsp70 function by a eukaryotic DnaJ homolog. J Biol Chem (1992) 2.46
A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem (1996) 2.44
Bhopal tragedy's health effects. A review of methyl isocyanate toxicity. JAMA (1990) 2.41
The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol (1975) 2.39
Glycosylation: heterogeneity and the 3D structure of proteins. Crit Rev Biochem Mol Biol (1997) 2.36
Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J (1994) 2.35
Australia antigen and hepatitis. N Engl J Med (1970) 2.35
Activation of posterior gap gene expression in the Drosophila blastoderm. Nature (1995) 2.30
Additional specificities of Australia antigen and the possible identification of hepatitis carriers. Nature (1969) 2.28
CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res (1999) 2.27
Australia antigen and the biology of hepatitis B. Science (1977) 2.23
Zim1, a maternally expressed mouse Kruppel-type zinc-finger gene located in proximal chromosome 7. Hum Mol Genet (1999) 2.20
Australia antigen and acute viral hepatitis. Ann Intern Med (1969) 2.20
Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein. Nature (1988) 2.17
Further studies on a "new" human isoprecipitin system (Australia antigen). Blood (1966) 2.16
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J (1996) 2.12
Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal Biochem (1997) 2.12
The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J Biol Chem (1998) 2.10
Family studies of a human serum isoantigen system (Australia antigen). Am J Hum Genet (1966) 2.10
N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biol Chem (1994) 2.05
Social class, coronary risk factors and undernutrition, a double burden of diseases, in women during transition, in five Indian cities. Int J Cardiol (1999) 2.04
Physiologic and metabolic factors in the pathogenesis of neonatal enteric infections in calves. J Am Vet Med Assoc (1972) 2.00
The high degree of internal flexibility observed for an oligomannose oligosaccharide does not alter the overall topology of the molecule. Eur J Biochem (1998) 2.00
Australia antigen detected in the nuclei of liver cells of patients with viral hepatitis by the fluorescent antibody technic. Nature (1969) 1.97
Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA (1968) 1.94
ASPP: a new family of oncogenes and tumour suppressor genes. Br J Cancer (2007) 1.94
An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol Cell Biol (1995) 1.92
Equine hepatic insufficiency. Vet Clin North Am (1973) 1.92
RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell (1999) 1.85
E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev (1997) 1.85
AsMamDB: an alternative splice database of mammals. Nucleic Acids Res (2001) 1.85
Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proc Natl Acad Sci U S A (1969) 1.84
Association between lepromatous leprosy and Australia antigen. Lancet (1967) 1.83
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain (2003) 1.82
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
Australia antigen and hepatitis. JAMA (1969) 1.81
Coronavirus protein processing and RNA synthesis is inhibited by the cysteine proteinase inhibitor E64d. Virology (1995) 1.80
Magnetic cross-relaxation among protons in protein solutions. Biochemistry (1978) 1.78
Identification and characterization of a serine-like proteinase of the murine coronavirus MHV-A59. J Virol (1995) 1.76
Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications. Hepatology (2001) 1.75
Aminosugar derivatives as potential anti-human immunodeficiency virus agents. Proc Natl Acad Sci U S A (1988) 1.75
A functional protein pore with a "retro" transmembrane domain. Protein Sci (1999) 1.73
Antiviral L-nucleosides specific for hepatitis B virus infection. Antimicrob Agents Chemother (2001) 1.72
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science (1997) 1.70
PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population. J Thromb Haemost (2012) 1.69
Australia antigen as a hepatitis virus. Variation in host response. Am J Med (1970) 1.69
Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet (1988) 1.68
Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol Immunol (1985) 1.68
A statistical analysis of N- and O-glycan linkage conformations from crystallographic data. Glycobiology (1999) 1.67
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1994) 1.66
Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1. EMBO J (1987) 1.66
Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem (2001) 1.65
Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci U S A (1994) 1.65
Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65
Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.64
Structure, biosynthesis, and function of glycosylphosphatidylinositols. Biochemistry (1990) 1.63
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma. Lancet (1975) 1.62
Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A (1999) 1.60
Aromatic cross-links in insect cuticle: detection by solid-state 13C and 15N NMR. Science (1987) 1.60
Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair. Mol Cell Biol (1995) 1.59
Conformation-independent binding of monoglucosylated ribonuclease B to calnexin. Cell (1997) 1.58
The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study. J Biol Chem (1997) 1.58
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect (2000) 1.58
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci U S A (1999) 1.54